
Board Meeting15 Jun 2026, 07:30 pm
Sudarshan Pharma Board Meeting on June 18 to Consider Fund Raising
AI Summary
Sudarshan Pharma Industries Ltd has announced that its Board of Directors will convene on June 18, 2026. The primary agenda item is to consider and approve a proposal for raising funds. The company may utilize instruments such as equity shares, convertible securities, warrants, or debt securities through methods like private placement, preferential issue, or qualified institutions placement. The board will also approve necessary ancillary actions for the fund-raising exercise, subject to regulatory approvals.
Key Highlights
- Board meeting scheduled for June 18, 2026.
- Proposal to raise funds will be considered.
- Fund raising may involve equity, convertible securities, or debt.
- Methods like private placement or QIP are options.
- Ancillary actions for fund raising to be approved.
Price Impact
More from SUDARSHAN